{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-006428","form_type":"8-K","ticker":"BCTX","cik":"0001610820","company_name":"BriaCell Therapeutics Corp.","filed_at":"2025-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.012142+00:00","generated_at":"2026-05-23T04:59:17.712638+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BriaCell closes $13.8M public offering of units with warrants","bullets":["Gross proceeds of ~$13.8M from 3,066,666 units at $4.50/unit, including 399,999 from over-allotment","Each unit consists of one common share (or pre-funded warrant) and one warrant exercisable at $5.25 for five years","Warrants commenced trading on Nasdaq under BCTXZ on April 25, 2025","Net proceeds to be used for working capital, general corporate purposes, and advancing business objectives","ThinkEquity acted as sole book-running manager; offering closed on April 28, 2025"],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-006428","json":"https://secwatch.observer/filing/0001641172-25-006428.json","markdown":"https://secwatch.observer/filing/0001641172-25-006428.md","text":"https://secwatch.observer/filing/0001641172-25-006428.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610820/000164117225006428/0001641172-25-006428-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610820/000164117225006428/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T04:59:17.712638+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}